跳至主要内容
临床试验/CTRI/2022/03/040862
CTRI/2022/03/040862尚未招募1 期

A Single arm clinical study to assess efficacy of Dadimadi Ghruta as an add on therapy in chemotherapy induced anemia

Dr Komal Shriram Indulkar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Post Chemotherapy patients on hematinic for one month without significant change in hemoglobin level
  • hemoglobin in female less than 12 gm/dl
  • hemoglobin in male less than 13.5 gm/dl

排除标准

  • Patients contra indicated for snehapana
  • Patients having thalassemia, sickle cell anemia and leukemia
  • Patients with low hemoglobin levels before chemotherapy

研究者

发起方
Dr Komal Shriram Indulkar

相似试验